Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Compares two pacemaker lead placements after heart rhythm ablation in atrial fibrillation

Tests His bundle pacing against right ventricular pacing in adults with heart failure.

Plain-language title generated from the registry record
Registry title: Ablate and Pace HIS Study

Key facts

Where
Leicester, United KingdomSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT06152406, who can take part

Where in United Kingdom

  • University Hospitals of Leicester NHS TrustLeicester, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospitals, Leicester
Trial code
NCT06152406
Record updated
5 January 2026
Original description
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. Despite the advances in AF ablation strategies, the outcome of ablation procedures in persistent AF is still unsatisfactory. In addition, many patients are not candidates for ablation due to advanced age, comorbidities and previous failed ablation procedures.Read full original descriptionShow less

Safety and Efficacy of Distal His Bundle Pacing Compared to Right Ventricular Pacing in Patients With Symptomatic Atrial Fibrillation Undergoing AV Node Ablation With Evidence of Heart Failure, a Randomised Control Study

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. Despite the advances in AF ablation strategies, the outcome of ablation procedures in persistent AF is still unsatisfactory. In addition, many patients are not candidates for ablation due to advanced age, comorbidities and previous failed ablation procedures.

It is well known that there is no mortality benefit from rhythm versus rate control strategy in AF, therefore the increased number of AV node ablation and pacemaker insertion for patients with symptomatic AF with uncontrolled heart rate. Following AV node ablation, it is understandable that these patients will be paced 100% of the time where the value of physiological pacing will be at its most.

The current standard practice is to pace the right ventricle for this cohort of patients unless they have severe LV systolic dysfunction when a biventricular pacing might be recommended. Previous data showed that RV pacing only can lead to deterioration of LV function, worsening of heart failure symptoms and increased mortality.

HIS bundle pacing is a novel technique of pacing through placing the pacemaker lead on the junction box between the top and bottom chamber of the heart. This will allow the utilisation of the normal/intrinsic HIS Purkinjie (eclectic cables) to stimulate the ventricles. This can offer a physiological pacing modality and reduce pacing induced cardiomyopathy specially in pacing dependent pacing.

The Ablate and Pace HIS Study proposes that the new method of HIS pacing is safe, effective and superior to the existing method of RV pacing in patients with atrial fibrillation who demonstrate signs of heart failure.

Inclusion: Aged 18 or above; Symptomatic AF, New York Heart Association (NYHA) class II-IV; Willing to consent for the study; AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following:; Impaired LV function, EF <50 %. And or; Raised N-Terminal Pro B-type Natriuretic Peptide ( NT-ProBNP) >365 ng/L.

Exclusion: Other serious medical condition with life expectancy of less than 1 year; Patient who has already got a pacemaker in situ; Known severe LVSD when biventricular device is the thought to be the preferred pacing modality; Females in child bearing period; Lack of capacity to consent; Less than 18 years; Unwilling to consent for the study.

ClinicalTrials.gov NCT06152406